Structure Therapeutics Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
GPCR on Nasdaq
Location
611 Gateway Blvd Suite 223, South San Francisco, CA

Insiders trading volume in the past year

Structure Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fmr Llc Other*, 10%+ Owner $27.6M -$471K -1.68% Jul 30, 2025
Ramy Farid Director $17.2M Feb 7, 2023
Jun Yoon Chief Financial Officer $9.09M Mar 15, 2025
Raymond C. Stevens CHIEF EXECUTIVE OFFICER, Director $8.38M Mar 15, 2025
Crespo Blas Coll Chief Medical Officer $1.73M Sep 18, 2025
Xichen Lin Chief Scientific Officer $1.4M Jul 1, 2025
Ashley Hall Chief Development Officer $870K Sep 18, 2025
Yingli Ma Chief Technology Officer $812K Jul 1, 2025
Melita Sun Jung Chief Business Officer $62.5K Feb 7, 2023
Sharon Tetlow Director Jun 23, 2025
Angus C. Russell Director Jun 23, 2025
Bvf Partners L P/Il 10%+ Owner May 10, 2023
FIL Ltd Other* Feb 7, 2023
Daniel G. Welch Director Jun 23, 2025
Ted W. Love Director Jun 23, 2025
Mark Allen Bach Chief Medical Officer Mar 15, 2024
Joanne Waldstreicher Director Jun 23, 2025
Eric Dobmeier Director Jun 23, 2025

Recent Insider Transactions by Companies or Individuals for Structure Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.